testing in human biological models

Agemica brings artificial intelligence and experimental biology together to fight aging, cancer, and disease. Its mission is to extend the healthy human lifespan to 150 years. The company designs therapeutic combinations, tests them in human biological models, and advances the most promising candidates. It reports up to 100% cancer-cell death in selected human cancer models at seven days with no observed cell death in tested healthy fibroblast controls.

Read more

Artificial Intelligencecomputational drug discoveryexperimental biologytherapeutic combination design